Download Brochures
Contact Us
Address
C 107, Sumel Business Park 6, Dudheshwar Road, Shahibaug, Ahmedabad, Gujarat-380004, India.
Mobile
+91 9898069199
+91 9898591099
Email
info@suretyhealthcare.com
C 107, Sumel Business Park 6, Dudheshwar Road, Shahibaug, Ahmedabad, Gujarat-380004, India.
Mobile
+91 9898069199
+91 9898591099
info@suretyhealthcare.com
TABLETS
| No | Product | Drug Class | Mode of Action |
| 1 | Aceclofenac 100 mg + Paracetamol 500 mg | NSAID + Analgesic/Antipyretic | Aceclofenac inhibits cyclooxygenase (COX) enzymes to reduce inflammation and pain, while paracetamol acts centrally to relieve pain and fever. |
| 2 | Aceclofenac 100 mg + Paracetamol 500 mg + Serratiopeptidase 15 mg | NSAID + Analgesic + Proteolytic enzyme | Reduces pain and inflammation; serratiopeptidase decreases inflammatory edema and promotes healing. |
| 3 | Albendazole 400 mg + Ivermectin 12 mg | Anthelmintic combination | Albendazole inhibits parasite microtubule synthesis; ivermectin causes paralysis of parasites by enhancing chloride ion permeability. |
| 4 | Albendazole Chewable 400 mg | Anthelmintic | Inhibits glucose uptake and microtubule formation in helminths, causing parasite death. |
| 5 | Alprazolam 0.25 mg | Benzodiazepine anxiolytic | Enhances GABA-mediated inhibitory neurotransmission in the CNS to reduce anxiety and induce sedation. |
| 6 | Alprazolam 0.50 mg | Benzodiazepine anxiolytic | Enhances GABA activity in the CNS producing anxiolytic and sedative effects. |
| 7 | Alprazolam 1 mg | Benzodiazepine anxiolytic | Potentiates GABA neurotransmission leading to CNS depression and anxiolytic action. |
| 8 | Artemether 20 mg + Lumefantrine 120 mg | Antimalarial combination | Artemether rapidly kills malaria parasites via free radical damage; lumefantrine inhibits parasite detoxification pathways. |
| 9 | Artemether 80 mg + Lumefantrine 480 mg | Antimalarial combination | Provides rapid and sustained antimalarial activity against Plasmodium species. |
| 10 | Aspirin 100 mg | Antiplatelet / NSAID | Irreversibly inhibits COX-1 enzyme and thromboxane A2 synthesis, reducing platelet aggregation. |
| 11 | Aspirin 150 mg | Antiplatelet / NSAID | Prevents platelet aggregation and reduces inflammation through COX inhibition. |
| 12 | Aspirin 75 mg | Antiplatelet agent | Low-dose aspirin inhibits platelet aggregation to reduce thrombotic risk. |
| 13 | Aspirin 80 mg | Antiplatelet agent | Inhibits thromboxane-mediated platelet aggregation and clot formation. |
| 14 | Atorvastatin Calcium 10 mg | HMG-CoA reductase inhibitor (Statin) | Reduces hepatic cholesterol synthesis and lowers LDL cholesterol levels. |
| 15 | Azithromycin 250 mg | Macrolide antibiotic | Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. |
| 16 | Azithromycin 500 mg | Macrolide antibiotic | Prevents bacterial protein synthesis and growth. |
| 17 | Apixaban Tablets 2.5 mg | Oral anticoagulant / Factor Xa inhibitor | Selectively inhibits factor Xa to prevent thrombin formation and clot development. |
| 18 | Apixaban Tablets 5 mg | Oral anticoagulant / Factor Xa inhibitor | Reduces blood coagulation by direct inhibition of factor Xa. |
| 19 | Betahistine Dihydrochloride 16 mg | Antivertigo agent | Improves inner ear microcirculation and decreases vestibular pressure. |
| 20 | Betahistine Dihydrochloride 8 mg | Antivertigo agent | Acts on histamine receptors to improve labyrinthine blood flow and reduce vertigo symptoms. |
| 21 | Bromhexine 8 mg | Mucolytic agent | Breaks down mucus structure and facilitates expectoration. |
| 22 | Calcium Carbonate 500 mg | Calcium supplement / Antacid | Replenishes calcium and neutralizes gastric acid. |
| 23 | Cetirizine 10 mg | Antihistamine (H1 blocker) | Blocks peripheral histamine H1 receptors to relieve allergic symptoms. |
| 24 | Ciprofloxacin 250 mg | Fluoroquinolone antibiotic | Inhibits bacterial DNA gyrase and topoisomerase IV, blocking DNA replication. |
| 25 | Ciprofloxacin 500 mg | Fluoroquinolone antibiotic | Prevents bacterial DNA synthesis leading to bacterial cell death. |
| 26 | Ciprofloxacin 500 mg + Tinidazole 600 mg | Antibiotic + Antiprotozoal | Ciprofloxacin acts against bacteria; tinidazole damages DNA of anaerobic organisms and protozoa. |
| 27 | Citicoline Sodium 500 mg | Nootropic / Neuroprotective agent | Enhances neuronal membrane repair and supports neurotransmitter synthesis. |
| 28 | Clarithromycin 250 mg | Macrolide antibiotic | Inhibits bacterial protein synthesis via 50S ribosomal binding. |
| 29 | Clarithromycin 500 mg | Macrolide antibiotic | Prevents bacterial growth through inhibition of protein synthesis. |
| 30 | Clonazepam 0.5 mg | Benzodiazepine anticonvulsant | Enhances GABA activity to provide anticonvulsant and anxiolytic effects. |
| 31 | Clonazepam 1 mg | Benzodiazepine anticonvulsant | Produces CNS inhibitory effects through GABA enhancement. |
| 32 | Clonazepam 2 mg | Benzodiazepine anticonvulsant | Suppresses seizure activity and anxiety by potentiating GABA neurotransmission. |
| 33 | Dapagliflozin 10 mg | Antidiabetic / SGLT2 inhibitor | Increases urinary glucose excretion by inhibiting renal glucose reabsorption. |
| 34 | Dapagliflozin 10 mg + Metformin Hydrochloride 1000 mg | Antidiabetic combination | Dapagliflozin promotes glucose excretion; metformin reduces hepatic glucose production and improves insulin sensitivity. |
| 35 | Dapagliflozin 10 mg + Metformin Hydrochloride 500 mg | Antidiabetic combination | Improves glycemic control through complementary renal and hepatic mechanisms. |
| 36 | Dapagliflozin 5 mg | Antidiabetic / SGLT2 inhibitor | Lowers blood glucose by blocking renal glucose reabsorption. |
| 37 | Dapagliflozin 5 mg + Metformin Hydrochloride 1000 mg | Antidiabetic combination | Enhances glucose control by increasing glucose excretion and decreasing hepatic glucose output. |
| 38 | Dapagliflozin 5 mg + Metformin Hydrochloride 500 mg | Antidiabetic combination | Dapagliflozin inhibits SGLT2 to increase urinary glucose excretion; metformin decreases hepatic glucose production and improves insulin sensitivity. |
| 39 | Dapoxetine 30 mg | Selective Serotonin Reuptake Inhibitor (SSRI) | Inhibits serotonin reuptake, increasing serotonin activity to delay ejaculation. |
| 40 | Dapoxetine 60 mg | Selective Serotonin Reuptake Inhibitor (SSRI) | Enhances serotonergic neurotransmission to improve ejaculatory control. |
| 41 | Dextromethorphan + Guaifenesin + Phenylephrine + Chlorphenamine | Antitussive / Expectorant / Decongestant / Antihistamine | Dextromethorphan suppresses cough center activity; guaifenesin loosens mucus; phenylephrine reduces nasal congestion; chlorphenamine blocks histamine H1 receptors. |
| 42 | Diazepam 10 mg | Benzodiazepine anxiolytic / Sedative | Enhances GABA-mediated CNS inhibition producing anxiolytic, muscle relaxant, anticonvulsant, and sedative effects. |
| 43 | Diazepam 5 mg | Benzodiazepine anxiolytic / Sedative | Potentiates GABA neurotransmission to reduce anxiety and CNS excitability. |
| 44 | Diclofenac Prolonged Release 100 mg | NSAID | Inhibits cyclooxygenase enzymes, reducing prostaglandin synthesis and inflammation. |
| 45 | Diclofenac Sodium + Paracetamol + Caffeine | NSAID + Analgesic + CNS stimulant | Diclofenac reduces inflammation; paracetamol relieves pain and fever; caffeine enhances analgesic efficacy. |
| 46 | Diclofenac Sodium 50 mg | NSAID | Reduces pain and inflammation by inhibiting prostaglandin synthesis. |
| 47 | Diclofenac Sodium 50 mg + Paracetamol 500 mg | NSAID + Analgesic | Provides combined anti-inflammatory, analgesic, and antipyretic action. |
| 48 | Dihydroartemisinin + Piperaquine Phosphate | Antimalarial combination | Dihydroartemisinin rapidly kills malaria parasites; piperaquine provides prolonged antimalarial action by interfering with parasite detoxification. |
| 49 | Domperidone 10 mg | Antiemetic / Prokinetic agent | Blocks dopamine D2 receptors, enhancing gastrointestinal motility and reducing nausea and vomiting. |
| 50 | Empagliflozin 10 mg | Antidiabetic / SGLT2 inhibitor | Inhibits renal glucose reabsorption, increasing urinary glucose excretion. |
| 51 | Empagliflozin 10 mg + Linagliptin 5 mg | Antidiabetic combination | Empagliflozin increases glucose excretion; linagliptin inhibits DPP-4, increasing incretin levels and insulin secretion. |
| 52 | Empagliflozin 25 mg | Antidiabetic / SGLT2 inhibitor | Lowers blood glucose by promoting glucose elimination through urine. |
| 53 | Empagliflozin 25 mg + Linagliptin 5 mg | Antidiabetic combination | Combines SGLT2 inhibition and DPP-4 inhibition for improved glycemic control. |
| 54 | Esomeprazole 20 mg | Proton Pump Inhibitor (PPI) | Irreversibly inhibits gastric proton pumps, reducing stomach acid secretion. |
| 55 | Esomeprazole 40 mg | Proton Pump Inhibitor (PPI) | Suppresses gastric acid production through inhibition of H+/K+ ATPase enzyme. |
| 56 | Etoricoxib 120 mg | Selective COX-2 inhibitor NSAID | Selectively inhibits COX-2 enzyme to reduce pain and inflammation with less gastric irritation. |
| 57 | Etoricoxib 60 mg | Selective COX-2 inhibitor NSAID | Reduces inflammatory prostaglandin synthesis via selective COX-2 inhibition. |
| 58 | Etoricoxib 90 mg | Selective COX-2 inhibitor NSAID | Provides analgesic and anti-inflammatory effects through COX-2 blockade. |
| 59 | Finasteride 5 mg | 5-alpha reductase inhibitor | Inhibits conversion of testosterone to dihydrotestosterone (DHT), reducing prostate enlargement and hair loss progression. |
| 60 | Folic Acid 4 mg | Vitamin B9 supplement | Supports DNA synthesis, red blood cell formation, and cell growth. |
| 61 | Flavoxate Tablets BP 100 mg | Urinary antispasmodic | Relaxes smooth muscles of the urinary tract to reduce bladder spasms and urinary symptoms. |
| 62 | Febuxostat 40 mg | Xanthine oxidase inhibitor / Antigout agent | Inhibits xanthine oxidase enzyme, reducing uric acid production. |
| 63 | Febuxostat 80 mg | Xanthine oxidase inhibitor / Antigout agent | Lowers serum uric acid levels by blocking xanthine oxidase activity. |
| 64 | Haloperidol 0.25 mg | Typical antipsychotic | Blocks dopamine D2 receptors in the CNS, reducing psychotic symptoms. |
| 65 | Haloperidol 1.5 mg | Typical antipsychotic | Produces antipsychotic effects through dopamine receptor antagonism. |
| 66 | Ibuprofen + Paracetamol + Caffeine | NSAID + Analgesic + CNS stimulant | Ibuprofen reduces inflammation; paracetamol relieves pain and fever; caffeine enhances analgesic response. |
| 67 | Ibuprofen + Thiocolchicoside | NSAID + Muscle relaxant | Ibuprofen reduces inflammation and pain; thiocolchicoside relieves muscle spasm through central muscle relaxant action. |
| 68 | Ketoprofen 100 mg | NSAID | Inhibits prostaglandin synthesis to reduce pain, inflammation, and fever. |
| 69 | Levetiracetam 500 mg | Antiepileptic | Modulates synaptic neurotransmitter release through binding to SV2A protein, reducing seizure activity. |
| 70 | Levofloxacin 250 mg | Fluoroquinolone antibiotic | Inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication. |
| 71 | Levofloxacin 500 mg | Fluoroquinolone antibiotic | Produces bactericidal action by blocking bacterial DNA synthesis. |
| 72 | Levofloxacin 750 mg | Fluoroquinolone antibiotic | Prevents bacterial replication through inhibition of DNA gyrase enzymes. |
| 73 | Levothyroxine 100 mcg | Thyroid hormone replacement | Replaces deficient thyroxine (T4), restoring normal metabolic activity and thyroid function. |
| 74 | Levothyroxine 50 mcg | Thyroid hormone replacement | Replaces deficient thyroxine (T4) to normalize metabolism and thyroid function. |
| 75 | Linagliptin 2.5 mg + Metformin Hydrochloride 1000 mg | Antidiabetic combination | Linagliptin inhibits DPP-4 increasing incretin activity; metformin reduces hepatic glucose production and improves insulin sensitivity. |
| 76 | Linagliptin 2.5 mg + Metformin Hydrochloride 500 mg | Antidiabetic combination | Enhances glycemic control through incretin enhancement and reduced glucose production. |
| 77 | Linagliptin 2.5 mg + Metformin Hydrochloride 850 mg | Antidiabetic combination | Combines DPP-4 inhibition with improved insulin sensitivity and reduced hepatic glucose output. |
| 78 | Linagliptin 5 mg | DPP-4 inhibitor antidiabetic | Inhibits DPP-4 enzyme, increasing incretin hormones and insulin secretion while reducing glucagon release. |
| 79 | Lisinopril 10 mg | ACE inhibitor antihypertensive | Inhibits conversion of angiotensin I to angiotensin II, causing vasodilation and lowering blood pressure. |
| 80 | Lisinopril 5 mg | ACE inhibitor antihypertensive | Reduces blood pressure and cardiac workload through angiotensin-converting enzyme inhibition. |
| 81 | Loperamide 2 mg | Antidiarrheal agent | Slows intestinal motility by acting on opioid receptors in the gut, reducing diarrhea frequency. |
| 82 | Loperamide 4 mg | Antidiarrheal agent | Decreases gastrointestinal motility and fluid loss in diarrhea. |
| 83 | Metformin 500 mg | Biguanide antidiabetic | Decreases hepatic glucose production and improves peripheral insulin sensitivity. |
| 84 | Metformin 850 mg | Biguanide antidiabetic | Lowers blood glucose by reducing gluconeogenesis and improving glucose uptake. |
| 85 | Metronidazole 500 mg | Nitroimidazole antibiotic / Antiprotozoal | Damages microbial DNA leading to death of anaerobic bacteria and protozoa. |
| 86 | Montelukast 10 mg + Fexofenadine 120 mg | Leukotriene receptor antagonist + Antihistamine | Montelukast blocks leukotriene-mediated airway inflammation; fexofenadine blocks H1 receptors to relieve allergy symptoms. |
| 87 | Naproxen 250 mg | NSAID | Inhibits prostaglandin synthesis to reduce pain, inflammation, and fever. |
| 88 | Naproxen 500 mg | NSAID | Produces analgesic and anti-inflammatory effects through COX inhibition. |
| 89 | Ofloxacin 200 mg + Ornidazole 500 mg | Antibiotic + Antiprotozoal | Ofloxacin inhibits bacterial DNA replication; ornidazole damages DNA of anaerobic organisms and protozoa. |
| 90 | Ofloxacin 400 mg | Fluoroquinolone antibiotic | Inhibits bacterial DNA gyrase and topoisomerase IV causing bacterial cell death. |
| 91 | Olanzapine 10 mg | Atypical antipsychotic | Antagonizes dopamine and serotonin receptors to reduce psychotic symptoms. |
| 92 | Olanzapine 5 mg | Atypical antipsychotic | Modulates dopamine and serotonin neurotransmission in the CNS. |
| 93 | Pantoprazole 20 mg | Proton Pump Inhibitor (PPI) | Suppresses gastric acid secretion by inhibiting H+/K+ ATPase proton pumps. |
| 94 | Pantoprazole 40 mg | Proton Pump Inhibitor (PPI) | Reduces stomach acid production through irreversible proton pump inhibition. |
| 95 | Paracetamol + Phenylephrine + Levocetirizine | Analgesic/Antipyretic + Decongestant + Antihistamine | Paracetamol relieves pain and fever; phenylephrine reduces nasal congestion; levocetirizine blocks histamine-mediated allergic symptoms. |
| 96 | Paracetamol 500 mg | Analgesic / Antipyretic | Acts centrally to reduce pain and fever. |
| 97 | Paracetamol + Phenylephrine + Chlorpheniramine | Analgesic + Decongestant + Antihistamine | Relieves fever, nasal congestion, and allergy symptoms through combined mechanisms. |
| 98 | Paracetamol + Chlorpheniramine + Phenylephrine + Caffeine | Cold and flu preparation | Provides analgesic, antihistaminic, decongestant, and mild stimulant effects for symptomatic relief of cold and flu. |
| 99 | Prednisolone 5 mg | Corticosteroid | Suppresses inflammatory and immune responses by modulating gene expression and cytokine production. |
| 100 | Phenobarbital Tablets BP 200 mg | Barbiturate anticonvulsant | Enhances GABA-mediated CNS inhibition to control seizures and sedation. |
| 101 | Quetiapine Fumarate 50 mg | Atypical antipsychotic | Blocks dopamine and serotonin receptors to stabilize mood and psychotic symptoms. |
| 102 | Quetiapine Fumarate 100 mg | Atypical antipsychotic | Modulates neurotransmitter activity in the CNS producing antipsychotic effects. |
| 103 | Quetiapine Fumarate 200 mg | Atypical antipsychotic | Reduces psychotic symptoms through serotonin and dopamine receptor antagonism. |
| 104 | Ramipril 5 mg | ACE inhibitor antihypertensive | Inhibits angiotensin-converting enzyme leading to vasodilation and reduced blood pressure. |
| 105 | Rivaroxaban 10 mg | Oral anticoagulant / Factor Xa inhibitor | Directly inhibits factor Xa to prevent thrombin generation and clot formation. |
| 106 | Rivaroxaban 20 mg | Oral anticoagulant / Factor Xa inhibitor | Reduces coagulation by selective inhibition of factor Xa. |
| 107 | Rosuvastatin 10 mg + Fenofibrate 160 mg | Antihyperlipidemic combination | Rosuvastatin lowers LDL cholesterol by inhibiting HMG-CoA reductase; fenofibrate activates PPAR-alpha to reduce triglycerides and improve lipid metabolism. |
| 108 | Sacubitril 24 mg + Valsartan 26 mg | ARNI (Angiotensin receptor neprilysin inhibitor) | Sacubitril inhibits neprilysin increasing natriuretic peptides; valsartan blocks angiotensin II receptors reducing vasoconstriction and cardiac workload. |
| 109 | Sacubitril 49 mg + Valsartan 51 mg | ARNI (Angiotensin receptor neprilysin inhibitor) | Improves heart failure outcomes through combined neprilysin inhibition and angiotensin receptor blockade. |
| 110 | Sacubitril 97 mg + Valsartan 103 mg | ARNI (Angiotensin receptor neprilysin inhibitor) | Sacubitril increases natriuretic peptides by neprilysin inhibition; valsartan blocks angiotensin II receptors, reducing vasoconstriction and cardiac workload. |
| 111 | Sildenafil 100 mg | PDE-5 inhibitor | Inhibits phosphodiesterase type-5, increasing cGMP levels and enhancing blood flow to erectile tissue. |
| 112 | Sildenafil 100 mg + Dapoxetine 60 mg | PDE-5 inhibitor + SSRI | Sildenafil improves erectile function by vasodilation; dapoxetine delays ejaculation through serotonin reuptake inhibition. |
| 113 | Sildenafil 50 mg | PDE-5 inhibitor | Enhances penile blood flow through nitric oxide-cGMP pathway potentiation. |
| 114 | Sitagliptin 25 mg | DPP-4 inhibitor antidiabetic | Inhibits DPP-4 enzyme, increasing incretin hormone levels to enhance insulin secretion and reduce glucagon release. |
| 115 | Sitagliptin 50 mg | DPP-4 inhibitor antidiabetic | Improves glycemic control by prolonging incretin activity. |
| 116 | Sitagliptin 100 mg | DPP-4 inhibitor antidiabetic | Enhances glucose-dependent insulin secretion through DPP-4 inhibition. |
| 117 | Sitagliptin 50 mg + Metformin HCl 500 mg | Antidiabetic combination | Sitagliptin increases incretin activity; metformin decreases hepatic glucose production and improves insulin sensitivity. |
| 118 | Sitagliptin 50 mg + Metformin HCl 1000 mg | Antidiabetic combination | Provides complementary glucose-lowering effects through incretin enhancement and reduced gluconeogenesis. |
| 119 | Tadalafil 20 mg | PDE-5 inhibitor | Relaxes smooth muscles and improves blood flow through inhibition of phosphodiesterase type-5 enzyme. |
| 120 | Tamsulosin 0.4 mg | Alpha-1 adrenergic blocker | Relaxes smooth muscles in the prostate and bladder neck, improving urinary flow in benign prostatic hyperplasia. |
| 121 | Telmisartan 20 mg | Angiotensin II receptor blocker (ARB) | Blocks angiotensin II receptors causing vasodilation and reduction in blood pressure. |
| 122 | Telmisartan 40 mg | Angiotensin II receptor blocker (ARB) | Reduces vasoconstriction and aldosterone effects through AT1 receptor blockade. |
| 123 | Telmisartan 40 mg + Amlodipine 5 mg | ARB + Calcium channel blocker | Telmisartan blocks angiotensin II-mediated vasoconstriction; amlodipine relaxes vascular smooth muscle by calcium channel inhibition. |
| 124 | Telmisartan 80 mg | Angiotensin II receptor blocker (ARB) | Lowers blood pressure through selective angiotensin II receptor antagonism. |
| 125 | Teneligliptin 20 mg | DPP-4 inhibitor antidiabetic | Inhibits DPP-4 enzyme to increase incretin hormones and improve glucose control. |
| 126 | Terbinafine 250 mg | Antifungal | Inhibits squalene epoxidase, disrupting fungal cell membrane synthesis. |
| 127 | Terbinafine 500 mg | Antifungal | Produces fungicidal action by inhibiting ergosterol biosynthesis in fungal cells. |
| 128 | Ticagrelor Tablets 90 mg | Antiplatelet agent / P2Y12 inhibitor | Reversibly inhibits platelet P2Y12 ADP receptors, preventing platelet aggregation. |
| 129 | Torsemide 10 mg | Loop diuretic | Inhibits sodium and chloride reabsorption in the loop of Henle, increasing urine output. |
| 130 | Torsemide 100 mg | Loop diuretic | Promotes diuresis and reduces fluid overload by blocking electrolyte reabsorption. |
| 131 | Torsemide 20 mg | Loop diuretic | Enhances excretion of sodium and water to reduce edema and blood pressure. |
| 132 | Tramadol 50 mg | Opioid analgesic | Acts on opioid receptors and inhibits reuptake of norepinephrine and serotonin to relieve pain. |
| 133 | Tramadol Hydrochloride 37.5 mg + Paracetamol 325 mg | Opioid analgesic + Analgesic | Tramadol provides central pain relief; paracetamol enhances analgesic and antipyretic effects. |
| 134 | Trimethoprim 160 mg + Sulfamethoxazole 800 mg | Antibacterial combination (Sulfonamide) | Sequentially inhibits bacterial folic acid synthesis, producing synergistic antibacterial action. |
| 135 | Trimethoprim 80 mg + Sulfamethoxazole 400 mg | Antibacterial combination (Sulfonamide) | Blocks bacterial folate metabolism to inhibit bacterial growth and survival. |
| 136 | Vildagliptin 50 mg + Metformin Hydrochloride 1000 mg | Antidiabetic combination | Vildagliptin enhances incretin activity; metformin improves insulin sensitivity and decreases glucose production. |
| 137 | Vildagliptin 50 mg + Metformin Hydrochloride 500 mg | Antidiabetic combination | Improves glycemic control through complementary incretin and insulin-sensitizing mechanisms. |
| 138 | Vitamin C 500 mg | Vitamin supplement / Antioxidant | Acts as an antioxidant and supports collagen synthesis, immunity, and tissue repair. |
| 139 | Zolpidem 10 mg | Non-benzodiazepine hypnotic | Enhances GABA-A receptor activity to induce sleep and reduce sleep latency. |
| 140 | Zolpidem 5 mg | Non-benzodiazepine hypnotic | Produces sedative-hypnotic effects through selective GABA receptor modulation. |
| 141 | Zopiclone 7.5 mg | Non-benzodiazepine hypnotic | Enhances GABA-mediated CNS inhibition to promote sleep initiation and maintenance. |
CAPSULES
| No | Product | Drug Class | Mode of Action |
| 1 | Acetylcysteine 200 mg | Mucolytic agent / Antioxidant | Breaks disulfide bonds in mucus, reducing mucus viscosity and improving airway clearance; also replenishes glutathione levels. |
| 2 | Celecoxib 200 mg | Selective COX-2 inhibitor NSAID | Selectively inhibits cyclooxygenase-2 enzyme, reducing prostaglandin synthesis and inflammation with less gastric irritation. |
| 3 | Fluconazole 150 mg | Antifungal (Triazole) | Inhibits fungal cytochrome P450-dependent ergosterol synthesis, disrupting fungal cell membrane formation. |
| 4 | Fluconazole 200 mg | Antifungal (Triazole) | Prevents fungal cell membrane synthesis by inhibiting ergosterol production. |
| 5 | Gabapentin 300 mg | Anticonvulsant / Neuropathic pain agent | Modulates calcium channel activity in neurons, reducing excitatory neurotransmitter release. |
| 6 | Ibuprofen + Paracetamol + Caffeine | NSAID + Analgesic + CNS stimulant | Ibuprofen reduces inflammation; paracetamol relieves pain and fever; caffeine enhances analgesic efficacy. |
| 7 | Itraconazole 100 mg | Antifungal (Triazole) | Inhibits ergosterol synthesis, impairing fungal cell membrane integrity. |
| 8 | Itraconazole 200 mg | Antifungal (Triazole) | Produces antifungal action by blocking fungal membrane sterol synthesis. |
| 9 | Lansoprazole 30 mg | Proton Pump Inhibitor (PPI) | Irreversibly inhibits gastric H+/K+ ATPase proton pumps, reducing acid secretion. |
| 10 | Omeprazole 20 mg | Proton Pump Inhibitor (PPI) | Suppresses gastric acid production through proton pump inhibition. |
| 11 | Pregabalin 150 mg | Anticonvulsant / Neuropathic pain agent | Binds to voltage-gated calcium channels reducing neurotransmitter release and nerve excitability. |
| 12 | Pregabalin 75 mg | Anticonvulsant / Neuropathic pain agent | Decreases abnormal neuronal excitability and neuropathic pain signaling. |
| 13 | Pregabalin 75 mg + Methylcobalamin 750 mcg | Neuropathic pain combination / Neurotropic supplement | Pregabalin reduces nerve pain signaling; methylcobalamin supports nerve repair and regeneration. |
| 14 | Rabeprazole Sodium 20 mg + Domperidone 30 mg | Proton Pump Inhibitor + Prokinetic/Antiemetic | Rabeprazole reduces gastric acid secretion; domperidone enhances gastrointestinal motility and reduces nausea. |
| 15 | Tramadol 100 mg | Opioid analgesic | Acts on opioid receptors and inhibits norepinephrine and serotoni |
EXTERNAL PREPARATION
| No | Product | Drug Class | Mode of Action |
| 1 | Adapalene 0.1% + ClindamycinPhosphate 1% Gel | Topical retinoid + Antibioticanti-acne preparation | Adapalene normalizeskeratinization and reduces comedone formation; clindamycin inhibits bacterialprotein synthesis against acne-causing bacteria. |
| 2 | Adapalene 0.1% + BenzoylPeroxide 2.5% Gel | Topical retinoid + Antibacterialanti-acne preparation | Adapalene reduces follicularblockage and inflammation; benzoyl peroxide releases free radicals that killacne-causing bacteria. |
| 3 | Beclomethasone + Gentamicin +Clioquinol + Tolnaftate Cream | Corticosteroid + Antibiotic +Antifungal combination | Beclomethasone reducesinflammation; gentamicin inhibits bacterial protein synthesis; clioquinol andtolnaftate inhibit fungal growth. |
| 4 | Betamethasone + ClotrimazoleCream | Corticosteroid + Antifungal | Betamethasone suppressesinflammatory responses; clotrimazole inhibits fungal ergosterol synthesis. |
| 5 | Betamethasone Dipropionate + Clotrimazole + Neomycin Cream | Corticosteroid + Antifungal + Antibiotic | Provides anti-inflammatory, antifungal, and antibacterial action for mixed skin infections. |
| 6 | Betamethasone Dipropionate + Gentamicin + Tolnaftate + Iodochlorhydroxyquinoline Cream | Corticosteroid + Antibiotic + Antifungal | Reduces inflammation and treatsbacterial and fungal skin infections through combined antimicrobialmechanisms. |
| 7 | Betamethasone Ointment 0.05% | Topical corticosteroid | Suppresses inflammatory andimmune responses in the skin by inhibiting inflammatory mediators. |
| 8 | Betamethasone Valerate + Neomycin Sulfate Cream | Corticosteroid + Antibiotic | Betamethasone reduces skininflammation; neomycin inhibits bacterial protein synthesis. |
| 9 | Clobetasol Propionate Cream0.05% | Super potent topicalcorticosteroid | Inhibits inflammatory cytokinesand immune responses to relieve severe inflammatory skin disorders. |
| 10 | Clobetasol Propionate Lotion0.05% | Super potent topicalcorticosteroid | Reduces inflammation, itching,and redness by suppressing local immune activity. |
| 11 | Clotrimazole Cream USP 1% | Topical antifungal | Inhibits fungal ergosterolsynthesis, disrupting fungal cell membrane integrity. |
| 12 | Clotrimazole + BeclomethasoneDipropionate + Gentamicin Cream | Antifungal + Corticosteroid +Antibiotic | Treats fungal infections withassociated inflammation and secondary bacterial infection. |
| 13 | Diclofenac Diethylamine + Linseed Oil + Methyl Salicylate + Menthol Gel | Topical NSAID / Counterirritantanalgesic | Diclofenac reduces inflammation;methyl salicylate and menthol provide analgesic and cooling effects; linseedoil supports anti-inflammatory action. |
| 14 | Fusidic Acid 2% + BetamethasoneValerate 0.1% | Topical antibiotic +Corticosteroid | Fusidic acid inhibits bacterialprotein synthesis; betamethasone reduces inflammation and itching. |
| 15 | Fusidic Acid Cream BP 2% | Topical antibiotic | Inhibits bacterial proteinsynthesis, especially against Gram-positive bacteria. |
| 16 | Hydroquinone 4% w/w | Depigmenting agent | Inhibits tyrosinase enzyme, reducing melanin synthesis and skin hyperpigmentation. |
| 17 | Ketoconazole Cream BP 2% | Topical antifungal | Inhibits ergosterol synthesis infungal cell membranes leading to fungal cell death. |
| 18 | Ketoconazole + ClobetasolPropionate + Neomycin Sulfate Cream | Antifungal + Corticosteroid + Antibiotic | Combines antifungal,anti-inflammatory, and antibacterial actions for mixed inflammatory skininfections. |
| 19 | Menthol, Eucalyptus Oil,Turpentine Oil & Methyl Salicylate Ointment/Gel | Topical analgesic / Counterirritant | Menthol and eucalyptus oilprovide cooling and soothing effects; methyl salicylate and turpentine oilincrease local blood flow and relieve muscular and joint pain throughcounterirritant action. |
| 20 | Ofloxacin + Ornidazole + Terbinafine Hydrochloride + Clobetasol Propionate Cream | Antibiotic + Antiprotozoal + Antifungal + Corticosteroid | Ofloxacin inhibits bacterial DNAreplication; ornidazole damages microbial DNA; terbinafine inhibits fungalcell membrane synthesis; clobetasol suppresses inflammation and itching. |
| 21 | Povidone Iodine Ointment USP 10%w/w | Topical antiseptic | Releases free iodine thatrapidly destroys bacteria, fungi, viruses, and other microorganisms throughoxidation. |
| 22 | Povidone Iodine Ointment USP 5%w/w | Topical antiseptic | Provides broad-spectrumantimicrobial action by releasing iodine that disrupts microbial proteins andcell structures. |
| 23 | Hydroquinone + MometasoneFuroate + Tretinoin Cream | Depigmenting agent +Corticosteroid + Retinoid | Hydroquinone reduces melaninsynthesis; mometasone decreases inflammation; tretinoin promotes skin cellturnover and enhances depigmentation. |
| 24 | Ketoconazole 2% + ZincPyrithione 1% Shampoo | Antifungal / Anti-dandruffpreparation | Ketoconazole inhibits fungalergosterol synthesis; zinc pyrithione reduces fungal growth and scalp flakingassociated with dandruff and seborrheic dermatitis. |
ORAL LIQUID & SUSPENSION
| No | Product | Drug Class | Mode of Action |
| 1 | Paracetamol Oral Suspension BP | Analgesic / Antipyretic | Acts centrally to reduce pain and fever by inhibiting prostaglandin synthesis in the CNS. |
| 2 | Ibuprofen Oral Suspension BP | NSAID | Inhibits cyclooxygenase (COX) enzymes, reducing prostaglandin synthesis responsible for pain, fever, and inflammation. |
| 3 | Albendazole Oral Suspension USP | Anthelmintic | Inhibits microtubule formation and glucose uptake in parasites, causing parasite death. |
| 4 | Metronidazole Oral Suspension BP | Nitroimidazole antibiotic / Antiprotozoal | Damages microbial DNA leading to death of anaerobic bacteria and protozoa. |
| 5 | DIGY-AT Suspension (Alumina, Magnesia, Sodium CMC & Simethicone) | Antacid / Antiflatulent | Alumina and magnesia neutralize gastric acid; simethicone reduces gas bubbles; sodium CMC acts as a stabilizing agent. |
| 6 | CAL-D-AT Suspension (Calcium and Vitamins) | Calcium and multivitamin supplement | Replenishes calcium and essential vitamins to support bone health and metabolic functions. |
| 7 | PARA-AT Suspension (Paracetamol Oral Suspension BP) | Analgesic / Antipyretic | Reduces fever and pain through central inhibition of prostaglandin synthesis. |
| 8 | Energy-AT Syrup (B-Complex, Vitamin D3, Lysine HCl & Protein) | Nutritional supplement / Multivitamin tonic | Supports energy metabolism, growth, immunity, protein synthesis, and bone health. |
| 9 | IUFEN Suspension (Ibuprofen Oral Suspension BP) | NSAID | Provides analgesic, antipyretic, and anti-inflammatory effects through COX inhibition. |
| 10 | LCM-AT Syrup (Levocetirizine + Montelukast) | Antihistamine + Leukotriene receptor antagonist | Levocetirizine blocks histamine H1 receptors; montelukast blocks leukotriene-mediated allergic and inflammatory responses. |
| 11 | MEDINOL (Paracetamol Syrup) | Analgesic / Antipyretic | Relieves pain and fever through central action on thermoregulatory centers. |
| 12 | RAA-IBUPARA (Ibuprofen + Paracetamol Suspension) | NSAID + Analgesic | Ibuprofen reduces inflammation; paracetamol relieves pain and fever. |
| 13 | RAA CIPFLOCIN (Ciprofloxacin Oral Suspension BP) | Fluoroquinolone antibiotic | Inhibits bacterial DNA gyrase and topoisomerase IV, preventing bacterial replication. |
| 14 | RAA FLOXA-MS (Ofloxacin + Metronidazole + Simethicone Suspension) | Antibiotic + Antiprotozoal + Antiflatulent | Ofloxacin inhibits bacterial DNA synthesis; metronidazole damages microbial DNA; simethicone reduces gas formation. |
| 15 | Azithromycin for Oral Suspension IP | Macrolide antibiotic | Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. |
| 16 | Amoxycillin for Oral Suspension | Penicillin antibiotic | Inhibits bacterial cell wall synthesis leading to bacterial cell death. |
| 17 | Amoxycillin Trihydrate for Oral Suspension | Penicillin antibiotic | Prevents bacterial cell wall formation through inhibition of peptidoglycan synthesis. |
| 18 | Cefaclor for Oral Suspension | Second-generation cephalosporin antibiotic | Inhibits bacterial cell wall synthesis causing bacterial lysis. |
| 19 | Cefadroxil for Oral Suspension | First-generation cephalosporin antibiotic | Produces bactericidal action by disrupting bacterial cell wall formation. |
| 20 | Cefalexin for Oral Suspension | First-generation cephalosporin antibiotic | Inhibits bacterial cell wall synthesis leading to bacterial death. |
| 21 | Cefdinir for Oral Suspension | Third-generation cephalosporin antibiotic | Interferes with bacterial cell wall synthesis and integrity. |
| 22 | Cefditoren Pivoxil for Oral Suspension | Third-generation cephalosporin antibiotic | Inhibits bacterial cell wall synthesis producing bactericidal activity. |
| 23 | Cefixime + Lactic Acid Bacillus Suspension | Third-generation cephalosporin antibiotic + Probiotic | Cefixime inhibits bacterial cell wall synthesis; lactic acid bacillus helps maintain healthy intestinal flora. |
| 24 | Cefixime Trihydrate for Oral Suspension | Third-generation cephalosporin antibiotic | Prevents bacterial cell wall synthesis causing bacterial death. |
| 25 | Cefixime + Lactic Acid Bacillus Suspension | Third-generation cephalosporin antibiotic + Probiotic | Combines antibacterial action with probiotic support to reduce gut flora imbalance. |
| 26 | Cefixime + Ofloxacin Suspension | Cephalosporin + Fluoroquinolone antibiotic | Cefixime inhibits bacterial cell wall synthesis; ofloxacin inhibits bacterial DNA gyrase and topoisomerase IV. |
| 27 | Cefixime Trihydrate Oral Suspension | Third-generation cephalosporin antibiotic | Prevents bacterial cell wall synthesis leading to bacterial death. |
| 28 | Cefpodoxime Proxetil Oral Suspension | Third-generation cephalosporin antibiotic | Inhibits bacterial cell wall synthesis producing bactericidal action. |
| 29 | Cefpodoxime Proxetil + Ofloxacin Suspension | Cephalosporin + Fluoroquinolone antibiotic | Cefpodoxime inhibits bacterial cell wall synthesis; ofloxacin blocks bacterial DNA replication. |
| 30 | Cefuroxime Axetil Oral Suspension | Second-generation cephalosporin antibiotic | Inhibits bacterial cell wall synthesis and bacterial growth. |
| 31 | Cephalexin Oral Suspension | First-generation cephalosporin antibiotic | Prevents bacterial cell wall formation causing bacterial cell death. |
| 32 | Ferrous Ascorbate, Folic Acid & Zinc Suspension | Hematinic / Nutritional supplement | Ferrous ascorbate replenishes iron stores; folic acid supports RBC synthesis; zinc aids immunity and tissue repair. |
| 33 | Sodium Feredetate, Folic Acid & Vitamin B12 Syrup | Hematinic / Anti-anemic supplement | Supplies iron, folic acid, and vitamin B12 for hemoglobin synthesis and red blood cell maturation. |
| 34 | Ambroxol HCl, Loratadine & Guaiphenesin Syrup | Mucolytic + Antihistamine + Expectorant | Ambroxol liquefies mucus; loratadine blocks histamine H1 receptors; guaiphenesin promotes mucus clearance. |
| 35 | Multivitamin & Mineral Syrup with Lysine | Multivitamin / Nutritional supplement | Supports metabolism, growth, immunity, and protein synthesis through vitamins, minerals, and lysine supplementation. |
| 36 | Levocetirizine + Montelukast Syrup | Antihistamine + Leukotriene receptor antagonist | Levocetirizine relieves allergic symptoms; montelukast blocks leukotriene-mediated inflammation. |
| 37 | Sodium Picosulfate Syrup | Stimulant laxative | Stimulates colonic peristalsis to promote bowel evacuation. |
| 38 | Sucralfate Suspension | Gastroprotective agent | Forms a protective barrier over gastric and duodenal ulcers, shielding them from acid and pepsin. |
| 39 | Disodium Hydrogen Citrate Syrup | Urinary alkalinizer | Alkalinizes urine to relieve burning micturition and reduce urinary acidity. |
| 40 | Cyproheptadine HCl + Tricholine Citrate Syrup | Antihistamine + Hepatoprotective/appetite stimulant | Cyproheptadine blocks histamine and stimulates appetite; tricholine citrate supports liver function and bile flow. |
| 41 | Sodium Picosulphate + Liquid Paraffin + Milk of Magnesia Suspension | Laxative combination | Sodium picosulphate stimulates bowel movement; liquid paraffin softens stool; milk of magnesia acts as an osmotic laxative. |
| 42 | Piracetam Syrup | Nootropic / Neuroprotective agent | Enhances neuronal metabolism and neurotransmission to improve cognitive function. |
| 43 | Tricholine Citrate Syrup IP | Hepatoprotective agent | Promotes bile flow and supports liver metabolism and fat processing. |
| 44 | Dextromethorphan Hydrobromide Syrup | Antitussive | Suppresses the cough center in the medulla to reduce dry cough. |
| 45 | Levocetirizine Dihydrochloride Syrup | Antihistamine | Blocks peripheral H1 histamine receptors to relieve allergy symptoms. |
| 46 | Calcium with Vitamin D3 Suspension | Calcium supplement / Bone health preparation | Calcium supports bone mineralization; vitamin D3 enhances calcium absorption. |
| 47 | Zinc Acetate Syrup | Mineral supplement | Replenishes zinc levels supporting immunity, growth, and tissue repair. |
| 48 | Fexofenadine Hydrochloride Suspension | Antihistamine | Selectively blocks H1 receptors to relieve allergic symptoms without significant sedation. |
| 49 | Ferric Ammonium Citrate, Protein Hydrolysate, L-Lysine, Vitamins & Zinc Syrup | Hematinic / Nutritional supplement | Supports hemoglobin formation, growth, appetite, and metabolism through iron, amino acids, vitamins, and minerals. |
| 50 | Deflazacort Suspension | Corticosteroid | Suppresses inflammation and immune responses by inhibiting inflammatory mediators. |
| 51 | Pidotimod Oral Solution | Immunostimulant | Enhances immune response by stimulating T-cell and macrophage activity. |
| 52 | Ofloxacin Suspension IP | Fluoroquinolone antibiotic | Inhibits bacterial DNA gyrase and topoisomerase IV to stop bacterial replication. |
| 53 | Ondansetron Oral Solution IP | Antiemetic / 5-HT3 receptor antagonist | Blocks serotonin 5-HT3 receptors to prevent nausea and vomiting. |
| 54 | Hydroxyzine Hydrochloride Syrup IP | Antihistamine / Anxiolytic | Blocks H1 receptors producing antiallergic and sedative effects. |
| 55 | Mefenamic Acid + Paracetamol Suspension | NSAID + Analgesic/Antipyretic | Mefenamic acid reduces inflammation and pain; paracetamol relieves pain and fever. |
| 56 | Ferrous Ascorbate + Folic Acid Suspension | Hematinic / Anti-anemic supplement | Iron replenishes hemoglobin stores while folic acid supports RBC formation. |
| 57 | Ivermectin + Albendazole Oral Suspension | Anthelmintic combination | Ivermectin paralyzes parasites; albendazole inhibits parasite glucose uptake and microtubule synthesis. |
